Skip to main content
Equibles
INFU logo

INFU · InfuSystem Holdings, Inc · Webcasts, Transcripts & Audio

Track INFU — free

Use INFU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INFU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$13.49 +0.33 (+2.51%)
Russell 2000 member Rebalance outlook locked
Market Cap
$253.15M
Shares
19.92M
Volume · Oct 5 137.76K Avg daily vol (3M) 143.88K

InfuSystem Holdings, Inc Webcasts

Earnings calls, investor updates, investor days and conferences for InfuSystem Holdings, Inc (INFU), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲2.7% $27.28M $443,000 '22 Q3 22-11-08 ▲8.7% $28.83M $107,000 '22 Q4 23-03-15 ▲13.5% $30.37M −$324,000 '23 Q1 23-05-04 ▲17.4% $31.73M $435,000 '23 Q2 23-08-03 ▲17% $31.91M $689,000 '23 Q3 23-11-07 ▲10.2% $31.77M $72,000 '23 Q4 24-03-14 ▲5.4% $32.00M −$1.11M '24 Q1 24-05-09 ▲6.2% $33.70M $717,000 '24 Q2 24-08-08 ▲10.7% $35.32M $1.81M '24 Q3 24-11-07 ▲6.5% $33.85M $933,000 '24 Q4 25-03-04 ▲8.5% $34.72M −$267,000 '25 Q1 25-05-08 ▲6.8% $36.00M $2.60M '25 Q2 25-08-05 ▲3.3% $36.49M $2.26M '25 Q3 25-11-04 ▲7% $36.23M $2.04M '25 Q4 26-02-24 ▼3% $33.68M $1.02M '26 Q1 26-05-07 LATEST ▲2.6% $36.93M $3.23M '26 Q2 26-08-04
Capital Markets Day
Investor event
2026-09-24
InfuSystem Holdings, Inc (INFU) September 2026 Capital Markets Day
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-04
InfuSystem Holdings, Inc (INFU) Q2 2026 Earnings Call Transcript
Positive tone Lymphedema business and CMS prior authorization ERP system implementation benefits Growth timeline and future aspirations
Revenue
$36.93M
▲ 2.6% YoY
Diluted EPS
$0.15
▲ 25% YoY
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
InfuSystem Holdings, Inc (INFU) Q1 2026 Earnings Call Transcript
Positive tone Wound care growth ERP system implementation GE Healthcare contract restructuring
Revenue
$33.68M
▼ 3% YoY
Diluted EPS
$0.05
Gross margin
58.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
InfuSystem Holdings, Inc (INFU) Q4 2025 Earnings Call Transcript
Confident tone Q4 financial highlights 2026 financial outlook Profitability and gross margin
Revenue
$36.23M*
▲ 7% YoY
Gross margin
56.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
InfuSystem Holdings, Inc (INFU) Q3 2025 Earnings Call Transcript
Positive tone Financial results and margin expansion Wound Care growth and integration Oncology business performance
Revenue
$36.49M
▲ 3.3% YoY
Diluted EPS
$0.11
▲ 37.5% YoY
Gross margin
57.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
InfuSystem Holdings, Inc (INFU) Q2 2025 Earnings Call Transcript
Positive tone Margin expansion and profitability Oncology business ChemoMouthpiece reimbursement
Revenue
$36.00M
▲ 6.8% YoY
Diluted EPS
$0.12
▲ 300% YoY
Gross margin
55.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
InfuSystem Holdings, Inc (INFU) Q1 2025 Earnings Call Transcript
Confident tone Q1 revenue and EBITDA growth CEO succession and leadership transition Segment performance (Patient Services and Device Solutions)
Revenue
$34.72M
▲ 8.5% YoY
Diluted EPS
$-0.01
Gross margin
55.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
InfuSystem Holdings, Inc (INFU) Q4 2024 Earnings Call Transcript
Confident tone Revenue Growth Across Business Lines Wound Care Initiative Ramp-Up 2024 Accretion Year Results
Revenue
$33.85M*
▲ 6.5% YoY
Gross margin
53.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
InfuSystem Holdings, Inc (INFU) Q3 2024 Earnings Call Transcript
Confident tone Sanara / Chemo Mouthpiece joint venture Device Solutions segment Revenue growth and records
Revenue
$35.32M
▲ 10.7% YoY
Diluted EPS
$0.08
▲ 166.7% YoY
Gross margin
53.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
InfuSystem Holdings, Inc (INFU) Q2 2024 Earnings Call Transcript
Confident tone Negative Pressure Wound Therapy expansion NOPAIN Act and Pain Management Oncology segment performance
Revenue
$33.70M
▲ 6.2% YoY
Diluted EPS
$0.03
▲ 50% YoY
Gross margin
49.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
InfuSystem Holdings, Inc (INFU) Q1 2024 Earnings Call Transcript
Confident tone Strategic outlook and pipeline Biomedical/Wound Care programs Profitability and margin expansion
Revenue
$32.00M
▲ 5.4% YoY
Diluted EPS
$-0.05
Gross margin
51.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-14
InfuSystem Holdings, Inc (INFU) Q4 2023 Earnings Call Transcript
Confident tone GE Healthcare biomedical services contract Wound Care and Sanara joint venture Core oncology and pump rental business
Revenue
$31.77M*
▲ 10.2% YoY
Gross margin
52.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
InfuSystem Holdings, Inc (INFU) Q3 2023 Earnings Call Transcript
Revenue
$31.91M
▲ 17% YoY
Diluted EPS
$0.03
▲ 50% YoY
Gross margin
48.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
InfuSystem Holdings, Inc (INFU) Q2 2023 Earnings Call Transcript
Revenue
$31.73M
▲ 17.4% YoY
Diluted EPS
$0.02
Gross margin
49.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
InfuSystem Holdings, Inc (INFU) Q1 2023 Earnings Call Transcript
Revenue
$30.37M
▲ 13.5% YoY
Diluted EPS
$-0.02
Gross margin
49.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-15
InfuSystem Holdings, Inc (INFU) Q4 2022 Earnings Call Transcript
Revenue
$28.83M*
▲ 8.7% YoY
Gross margin
48.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
InfuSystem Holdings, Inc (INFU) Q3 2022 Earnings Call Transcript
Revenue
$27.28M
▲ 2.7% YoY
Diluted EPS
$0.02
Gross margin
59.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
InfuSystem Holdings, Inc (INFU) Q2 2022 Earnings Call Transcript
Revenue
$27.04M
▲ 8.9% YoY
Diluted EPS
$-0.01
▼ 125% YoY
Gross margin
55.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
InfuSystem Holdings, Inc (INFU) Q1 2022 Earnings Call Transcript
Revenue
$26.76M
▲ 9.4% YoY
Diluted EPS
$-0.02
▼ 166.7% YoY
Gross margin
57.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
InfuSystem Holdings, Inc (INFU) Q4 2021 Earnings Call Transcript
Revenue
$26.52M*
▲ 7.3% YoY
Gross margin
51.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-15
InfuSystem Holdings, Inc (INFU) Q3 2021 Earnings Call Transcript
Revenue
$26.57M
▲ 5.7% YoY
Diluted EPS
$-0.02
▼ 114.3% YoY
Gross margin
57.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
InfuSystem Holdings, Inc (INFU) Q2 2021 Earnings Call Transcript
Revenue
$24.83M
▼ 4.5% YoY
Diluted EPS
$0.04
▼ 78.9% YoY
Gross margin
60.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
InfuSystem Holdings, Inc (INFU) Q1 2021 Earnings Call Transcript
Revenue
$24.46M
▲ 13.5% YoY
Diluted EPS
$0.03
Gross margin
59.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-17
InfuSystem Holdings, Inc (INFU) Q4 2020 Earnings Call Transcript
Revenue
$24.71M*
▲ 13.8% YoY
Gross margin
60.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
InfuSystem Holdings, Inc (INFU) Q3 2020 Earnings Call Transcript
Revenue
$25.12M
▲ 16.9% YoY
Diluted EPS
$0.14
▲ 180% YoY
Gross margin
60.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-13
InfuSystem Holdings, Inc (INFU) Q2 2020 Earnings Call Transcript
Revenue
$26.00M
▲ 31.8% YoY
Diluted EPS
$0.19
▲ 850% YoY
Gross margin
61.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
InfuSystem Holdings, Inc (INFU) Q1 2020 Earnings Call Transcript
Revenue
$21.55M
▲ 18.5% YoY
Diluted EPS
$-0.02
Gross margin
58.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-19
InfuSystem Holdings, Inc (INFU) Q4 2019 Earnings Call
Revenue
$21.71M*
▲ 23.6% YoY
Gross margin
59.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 webcasts
Key facts CIK 1337013 CUSIP 45685K102 13F (30d) 1 filings 1 filers Visit website Investor relations